Patient characteristics

Propofol (n = 43)

Etomidate (n = 55)

p-value

Age, yrs1

57 ± 18.2

63 ± 17.2

0.12

Male sex, n (%)

19 (44.2)

24 (43.6)

0.31

Height (cm)1

169.2 ± 26.9

144.3 ± 61.3

0.15

Weight (kg)1

74.8 ± 18.6

74.1 ± 29.5

0.57

APACHE II2

22 (15 - 26)

21 (17 - 25)

0.23

Comorbidities

Hypertension

27 (62.7)

42 (76.3)

0.18

Diabetes

11 (25.5)

19 (34.5)

0.38

Malignancy

13 (30.2)

17 (30.9)

0.99

COPD

2 (4.6)

6 (10.9)

0.45

CHF

5 (11.6)

9 (16.3)

0.57

Tobacco smoker

11 (25.5)

6 (10.9)

0.06

Abnormal LFTs

7 (16.3)

11 (20.0)

0.79

Cirrhosis

4 (9.3)

7 (62.7)

0.75

ESRD

3 (6.9)

6 (12.7)

0.72

Prior intubations

1 (2.3)

0 (0)

0.43

Baseline laboratory tests

SCr

1.1 ± 0.5

2.3 ± 0.6

0.25

BUN

25.1 ± 17.3

26.7 ± 18.9

0.64

WBC

12.2 ± 5.6

11.9 ± 5.1

0.84

pH

7.3 ± 0.1

7.3 ± 0.2

0.27

Baseline vital signs

Heart rate

102.9 ± 32.9

93.9 ± 25.5

0.08

Respiratory rate

20.7 ± 7.5

21.1 ± 6.8

0.10

SBP (mmHg)

139.2 ± 29.7

136.8 ± 33.6

0.71

DBP (mmHg)

74.4 ± 20.5

71.7 ± 18.4

0.50

MAP

95.9 ± 22.2

92.9 ± 21.0

0.51

Temperature (F)

97.9 ± 2.0

97.7 ± 1.7

0.10